Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asterand
New DNA technology used by tissue-banking firm to study diabetes
June 26th, 2004
Asterand, the Detroit-based, venture-backed tissue banking company, is adopting new DNA amplification technology as part of a major international study to investigate the causes and cures for diabetes. The technology will permit scientists to extract genetic information from tiny quantities of human material such as a few cells obtained by donors using a simple mouthwash. It is being used by Asterand for the first time in Europe. "The diabetes study is in cooperation with Wayne State University researchers and researchers in Europe," said Asterand chief scientific officer James Eliason. "The trial involves obtaining blood samples from people...
Source: Law & Health Weekly (2004-06-26)
|
